Best Practice
As an open access journal, Development & Reproduction (DR) will follow the Principles of Transparency and Best Practice in Scholarly Publishing version 4.0 (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).
1. Name of Journal
The official journal title is Development & Reproduction, the abbreviation of ISO is Dev. Reprod.
2. Website
The URL of official journal web site is https://www.ksdb.org.
The editorial team endeavors to make a good website. Our website demonstrates that care has been taken to ensure high ethical and professional standards. It does not contain any misleading information, including any attempt to mimic another journal/publisher’s site.
3. Publishing Schedule
DR is published 4 times (March 31, June 30, September 30, and December 31) a year.
4. Archiving
It is accessible without barrier from Korea Citation Index (https://kci.go.kr) or National Library of Korea (https://nl.go.kr) in the event a journal is no longer published. Full text of JAST has been archived in PubMed Central (PMC; https://www.ncbi.nlm.nih.gov/pmc/journals/2584). Authors cannot archive pre-print (i.e., pre-refereeing), and they can archive post-print (i.e., final draft post-refereeing). Authors can archive publisher’s version/PDF.
5. Copyright
Copyright to all published materials is owned by Korean Society of Developmental Biology. All authors should agree to the copyright transfer during the submission process.
6. Licensing
DR is an open access journal. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To use the tables or figures of DR in other journals, books or media for scholarly, educational purposes, the process of permission request to the publisher is not necessary. All contents of the journal are available immediately upon publication without embargo period.
7. Publication Ethics and Related Editorial Policies
DR follows the Guideline on Good Publication of COPE (https://publicationethics.org) and Recommendations of International Committee of Medical Journal Editors (https://www.icmje.org/recommendations).
Our publication ethics are displayed on the Research and Publication Ethics of journal homepage.
The Editorial Board carefully examines whether all submitted manuscripts abide the ethical guidelines of ICMJE and COPE.
When the journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by COPE (https://publicationethics.org/guidance). The Editorial Board will discuss the suspected cases and reach a decision. DR will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.
8. Peer Review
The DR has on online submission and peer review system at https://submission.ksdb.org.DR adopts double-blind peer review and reviews all manuscripts received. A manuscript is first reviewed for its format and adherence to the aims and scope of the journal. If the manuscript does not fit the aims and scope of the Journal or does not adhere to the Instructions for authors, it may be returned to the author immediately after receipt and without a review. Before reviewing, all submitted manuscripts are inspected by Similarity Check powered by iThenticate (https://www.crossref.org/services/similarity-check/), a plagiarism-screening tool.
The manuscripts are sent to two or more most relevant investigators for review of the contents. The editor selects peer referees by recommendation of the Editorial Board members or from the specialist database owned by the Editorial Board. The peer review process takes usually 4 to 8 weeks after the manuscript submission.
9. Access
DR is an open access journal. A free full-text service, both in XML and PDF formats, is available immediately upon publication without an embargo period.
10. Ownership and Management
This journal is owned by the publisher, Korean Society of Developmental Biology.
The journal is managed by the editorial board.
11. Advisory Body
The advisory body is the journal's editorial board. The full names and affiliations of the journal’s editors are displayed on the Editorial Board of the journal website.
12. Editorial Team and Contact Information
The full names and affiliations of the journal’s editors and members of journal management team are displayed on the Editorial Board of journal homepage, and the contact information for the editorial office is on the Contact Information.
13. Author Fees
https://www.ksdb.org/info/charge
14. Other Revenue
Revenue sources of journal are from the support of publisher (Korean Society of Developmental Biology) and author fees.
15. Advertising
DR does not accept any commercial product advertisements until policy changes otherwise.
16. Direct Marketing
Journal propagation has been done through the journal website and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.
